Loading provider…
Loading provider…
Neurology Physician in Miami, FL
NPI: 1649699570Primary Employer
UMiami Medicine - Neurology
umiamihealth.org
HQ Phone
Get MD Ruham's Phone NumberMobile
Get MD Ruham's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2022 - 2027
NY State Medical License
2018 - 2023

American Board of Psychiatry and Neurology
Neurology

United Council For Neurologic Subspecialties
Neuro-oncology Certification
SUNY Upstate Medical University
upstate.edu
Chief Residency • Neurology
2017 - 2018
Residency • Neurology
2015 - 2018
Memorial Sloan Kettering Cancer Center
Fellowship • Neuro-Oncology
2018 - 2020
Icahn School of Medicine at Mount Sinai/Morningside/West
Residency • Internal Medicine
2014 - 2015
University of Aleppo Faculty of Medicine
Medical School
Until 2010
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 30 | 53 |
Rosai-Dorfman-Destombes disease of the nervous system: a systematic literature review.
L-Carnitine for Treatment of Pegasparaginase-Induced Hepatotoxicity
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, BIOLOGICAL: Nivolumab, PROCEDURE: Biospecimen Collection, DRUG: Lomustine, PROCEDURE: Biopsy Procedure, PROCEDURE: Surgical Procedure, BIOLOGICAL: Relatlimab
Lead Sponsor: NovoCure Ltd.
Intervention / Treatment: DEVICE: Optune®
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: Genentech, Inc., National Cancer Institute (NCI), Eli Lilly and Company, Mirati Therapeutics Inc., Kazia Therapeutics Limited
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Entrectinib, DRUG: Adagrasib, DRUG: PI3K Inhibitor paxalisib